Keywords :
Pelvic organ prolapse, Premenopausal women, Severity
Citation Information :
Garg M, Sharma R, Banerjee BD, Suneja A, Guleria K. Association of HOXA13 Gene Expression among Premenopausal Women with the Severity of Pelvic Organ Prolapse: A Cross-sectional Study. J South Asian Feder Obs Gynae 2022; 14 (4):420-423.
Aim: To determine the association of HOXA13 gene expression in vaginal wall tissue with the severity of pelvic organ prolapse (POP) among premenopausal women. Materials and methods: A cross-sectional study was conducted on a total of 60 premenopausal women. Subjects with ≥stage II POP were enrolled as cases, while those with benign gynecological conditions other than prolapse were taken as controls. Vaginal tissues were obtained during surgical procedures and HOXA13 gene analysis was done using real-time polymerase chain reaction. Spearman rank correlation coefficient was used for the correlation of true fold change of HOXA13 gene with other parameters. Results: Overall, HOXA13 gene was observed 1.21-fold downregulated in women with POP (p = 0.38). The gene was diminished in higher stages (stage III and stage IV) of POP (p = 0.007). It was found downregulated in most (84.21%) of the females above 40 years (p = 0.01). Conclusion: Downregulation of HOXA13 gene was seen in the majority of the women with POP, though not statistically significant. The gene expression was significantly diminished in women with advanced stages of prolapse (stage III and stage IV) as well as in women with age above 40 years. Clinical significance: Downregulation of HOXA13 gene can be one of the etiological factors of POP. Hence, preventive strategies may be developed using its gene expression analysis in future.
American College of Obstetricians and Gynecologists. Pelvic organ prolapse. ACOG technical bulletin. Int J Gynaecol Obstet 1996;52(2):197–205. PMID: 8855109.
Olsen AL, Smith VJ, Bergstrom JO. Epidemiology of surgically managed pelvic-organ prolapse and urinary incontinence. Obstet Gynecol 1997;89(4):501–506. DOI: 10.1016/S0029-7844(97)00058-6.
Vergeldt TF, Weemhoff M, IntHout J. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J 2015;26(11):1559–1573. DOI: 10.1007/s00192-015-2695-8.
Kuncharapu I, Majeroni BA, Johnson DW. Pelvic organ prolapse. Am Fam Physician 2010;81(9):1111–1117. PMID: 20433127.
Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998;25(4):723–746. DOI: 10.1016/s0889-8545(05)70039-5.
Twiss C, Triaca V, Rodríguez LV. Familial transmission of urogenital prolapse and incontinence. Curr Opin Obstet Gynecol 2007;19(5):464–468. DOI: 10.1097/GCO.0b013e3282efdc21.
Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997;57(6):1338–1345. DOI: 10.1095/biolreprod57.6.1338.
Taylor HS. Endocrine disruptors affect developmental programming of HOX gene expression. Fertil Steril 2008;89(2 Suppl):e57–e58. DOI: 10.1016/j.fertnstert.2007.12.030.
Williams TM, Williams ME, Kuick R. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability. Dev Biol 2005;279(2):462–480. DOI: 10.1016/j.ydbio.2004.12.015.
Drewes PG, Yanagisawa H, Starcher B. Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina. Am J Pathol 2007;170(2):578–589. DOI: 10.2353/ajpath.2007.060662.
Barker TH, Baneyx G, Cardó-Vila M. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 2005;280(43):36483–36493. DOI: 10.1074/jbc.M504663200.
Connell KA, Guess MK, Chen H. HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. J Clin Invest 2008;118(3):1050–1055. DOI: 10.1172/JCI34193.
Connell KA, Guess MK, Chen H. HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments. Reprod Sci 2009;16(7):694–700. DOI: 10.1177/1933719109334260.
Yılmaz N, Ozaksit G, Terzi YK. HOXA11 and MMP2 gene expression in uterosacral ligaments of women with pelvic organ prolapse. J Turk Ger Gynecol Assoc 2014;15(2):104–108. DOI: 10.5152/jtgga.2014.0088.
Connell KA, Guess MK, Tate A. Diminished vaginal HOXA13 expression in women with pelvic organ prolapse. Menopause 2009;16(3):529. DOI: 10.1097/gme.0b013e31818fb0c2.
Dökmeci F, Tekşen F, Çetinkaya ŞE. Expressions of homeobox, collagen and estrogen genes in women with uterine prolapse. Eur J Obstet Gynecol Reprod Biol 2019;233:26–29. DOI: 10.1016/j.ejogrb.2018.11.019.
Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol 2020;46(1):5–14. DOI: 10.1590/S1677-5538.IBJU.2018.0581.
Ramalingam K, Monga A. Obesity and pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol 2015;29(4):541–547. DOI: 10.1016/j.bpobgyn.2015.02.002.
de Sam Lazaro S, Nardos R, Caughey AB. Obesity and pelvic floor dysfunction: battling the bulge. Obstet Gynecol Surv 2016;71(2):114–125. DOI: 10.1097/OGX.0000000000000274.
Giri A, Hartmann KE, Hellwege JN. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol 2017;217(1):11–26. DOI: 10.1016/j.ajog.2017.01.039.
Swift S, Woodman P, O'Boyle A. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005;192(3):795–806. DOI: 10.1016/j.ajog.2004.10.602.
Reay Jones NH, Healy JC, King LJ. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg 2003;90(4):466–472. DOI: 10.1002/bjs.4065.
